{"id":10429,"date":"2026-10-09T13:53:07","date_gmt":"2026-10-09T11:53:07","guid":{"rendered":"https:\/\/mumak.me\/?p=10429"},"modified":"2026-10-09T14:36:43","modified_gmt":"2026-10-09T12:36:43","slug":"mumak-spotlight-of-the-week-spacex-takes-the-lead-technology-rotation-continues","status":"publish","type":"post","link":"https:\/\/mumak.me\/en\/portfolio-updates\/mumak-spotlight\/mumak-spotlight-of-the-week-spacex-takes-the-lead-technology-rotation-continues\/","title":{"rendered":"MUMAK Spotlight of the week: SpaceX takes the lead \u2013 Technology rotation continues"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The UMBRELLA Strategy continued its portfolio rotation towards Artificial Intelligence and advanced technologies this week.<\/p>

SpaceX<\/strong><\/a> became the largest position after further purchases, while Palantir Technologies<\/strong><\/a> was significantly increased. Dell Technologies<\/strong><\/a> was added as a new stock, further strengthening the focus on AI infrastructure.<\/p>

At the same time, Bayer<\/strong><\/a> was completely sold off, while positions in Revolution Medicines<\/strong><\/a> and Johnson & Johnson<\/strong><\/a> were reduced. These adjustments reflect a stronger concentration on technology alongside selective engagement in the healthcare sector.<\/p>

The portfolio currently comprises nine positions with an equity ratio of 97.4% and a liquidity ratio of 2.6%.<\/p>

SpaceX: New Largest Position and RED HOT CHILI MUMAK of the Week<\/h2>

SpaceX<\/strong><\/a> has risen to become the largest position within the UMBRELLA Strategy.<\/p>

Its weighting increased from approximately 13.4% to 18.4%, surpassing SpaceX<\/a><\/strong>‘s previous largest position, Revolution Medicines.<\/p>

Operational developments also remained in focus. SpaceX<\/a><\/strong> continued preparations for Starship launches from Florida.<\/p>

With a performance of approximately +16.7% since its inclusion, SpaceX<\/a><\/strong> was named this week’s RED HOT CHILI MUMAK. This award underscores the company’s growing importance within the strategy.<\/p>

Palantir Technologies: Position Significantly Increased<\/h2>

The position in Palantir Technologies<\/a><\/strong> was significantly expanded. The portfolio weighting increased from approximately 13.3% last week to currently 17.9%.<\/p>

With a performance of approximately +12.3% since its inclusion, Palantir<\/a><\/strong> is now the second-largest position in the strategy.<\/p>

Dell Technologies: New Addition to the UMBRELLA Strategy<\/h2>

A new stock, Dell Technologies<\/a><\/strong>, was added to the UMBRELLA Strategy. The position currently has a weighting of approximately 3.2%.<\/p>

Dell<\/a><\/strong> complements the existing semiconductor positions in Micron Technology and Intel, expanding the strategy’s engagement in various areas of the AI infrastructure market.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Dell Technologies \u2013 Stock Short Profile<\/a><\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Revolution Medicines: Position Reduced After Price Weakness<\/h2>

Revolution Medicines<\/a><\/strong> again came under selling pressure during the week, accompanied by broader weakness in the biotechnology sector.<\/p>

On October 6, biotechnology stocks experienced significant price losses, which also affected Revolution Medicines<\/a><\/strong>. The decline reflected a generally subdued market sentiment in the biotechnology sector, without a clearly identifiable new company-specific setback.<\/p>

In the wake of the price weakness, the position in Revolution Medicines<\/a><\/strong> within the UMBRELLA Strategy was reduced.<\/p>

Despite the adjustment, Revolution Medicines<\/a><\/strong> remains an important position in the healthcare sector.<\/p>

Bayer: Complete Exit from the Strategy<\/h2>

Bayer<\/a><\/strong> was completely sold off from the UMBRELLA Strategy.<\/p>

Following sustained price weakness, the remaining position was closed at prices between approximately EUR 43.00 and EUR 44.15. The reported losses ranged between approximately -2.6% and -5.1%.<\/p>

This exit concludes the recent series of position reductions in Bayer<\/a><\/strong>. At the same time, capital is freed up for the strategy’s stronger technology focus.<\/p>

Micron and Intel: Volatility in the Semiconductor Sector<\/h2>

The semiconductor sector again experienced increased volatility. Concerns about the pace of AI-related investments weighed on technology stocks.<\/p>

Micron Technology and Intel were also affected by the broader price declines in the semiconductor sector. However, long-term interest in AI infrastructure and demand from data centers remained.<\/p>

Both companies remain significant positions within the UMBRELLA Strategy, with current weightings of approximately 12.0% for Micron and 10.7% for Intel.<\/p>

Johnson & Johnson: Weighting in Healthcare Sector Reduced<\/h2>

The position in Johnson & Johnson<\/a><\/strong> was partially reduced. The weighting decreased from approximately 9.0% last week to currently 6.2%.<\/p>

Eli Lilly<\/a><\/strong> remains part of the strategy with a weighting of 9.3%, continuing to ensure selective engagement in the healthcare sector.<\/p>

Current Positioning of the UMBRELLA Strategy<\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\n\t\t\t\t\t<\/tr>
Position <\/th>Weighting<\/th>Performance since inclusion<\/th>\t\t\t\t<\/tr>\n\t\t\t<\/thead>\n\t\t\t\t\t\t
SpaceX <\/b><\/td> 18.3%<\/b><\/td> +16.4%<\/b><\/td><\/tr>
Palantir Technologies <\/b><\/td> 17.9%<\/b><\/td> +12.6%<\/b><\/td><\/tr>
Revolution Medicines <\/b><\/td> 15.4%<\/b><\/td> +19.6%<\/b><\/td><\/tr>
Micron Technology<\/b><\/td> 12.0%<\/b><\/td> +1.8%<\/b><\/td><\/tr>
Intel <\/b><\/td> 10.7%<\/b><\/td>\u22126.8% <\/b><\/td><\/tr>
Eli Lilly <\/b><\/td> 9.3%<\/b><\/td> +8.8%<\/b><\/td><\/tr>
Johnson & Johnson <\/b><\/td> 6.2%<\/b><\/td> +7.2%<\/b><\/td><\/tr>
Alphabet<\/b><\/td> 4,3 %<\/b><\/td> +2,3 %<\/b><\/td><\/tr>
Dell Technologies <\/b><\/td> 3.2%<\/b><\/td> +0.7%<\/b><\/td>\t\t\t\t<\/tr>\n\t\t\t<\/tbody>\n\t\t<\/table>\n\t\t\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Equity ratio: 97.4%<\/p>

Liquidity: 2.6%<\/p>

Source: wikifolio.com, UMBRELLA Strategy, Portfolio status as of October 9, 2026.<\/em><\/p>

Inside UMBRELLA Podcast<\/h3>

Do you want to know more about the UMBRELLA Strategy? <\/span> <\/span><\/p>

Then listen to the \u201cInside UMBRELLA\u201d podcast: <\/span><\/p> \t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Conclusion<\/h2>

The past week marked another important step in the technology-oriented reorientation of the UMBRELLA Strategy.<\/p>

SpaceX<\/a><\/strong> and Palantir<\/a><\/strong> now account for more than 36% of the portfolio, while the new addition of Dell Technologies<\/a><\/strong> further expands the commitment to AI infrastructure.<\/p>

At the same time, the complete exit from Bayer<\/a><\/strong> and the reductions in Revolution Medicines<\/a><\/strong> and Johnson & Johnson<\/a><\/strong> illustrate the ongoing adaptation of the portfolio to market developments.<\/p>

With nine positions and an equity ratio of 97.4%, the strategy remains focused on Artificial Intelligence, semiconductors, advanced technologies, and selected companies from the healthcare sector.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

SpaceX becomes the largest position, Palantir gains weight, and Dell Technologies is newly added to the UMBRELLA Strategy.<\/p>\n","protected":false},"author":2,"featured_media":2171,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[221],"tags":[622,624,555,346,362,158],"aktie":[],"class_list":["post-10429","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mumak-spotlight","tag-dell","tag-dell-technologies","tag-spacex","tag-kunstliche-intelligenz","tag-palantir-technologies","tag-umbrella-strategy"],"acf":[],"_links":{"self":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/10429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/comments?post=10429"}],"version-history":[{"count":8,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/10429\/revisions"}],"predecessor-version":[{"id":10471,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/posts\/10429\/revisions\/10471"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/media\/2171"}],"wp:attachment":[{"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/media?parent=10429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/categories?post=10429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/tags?post=10429"},{"taxonomy":"aktie","embeddable":true,"href":"https:\/\/mumak.me\/en\/wp-json\/wp\/v2\/aktie?post=10429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}